| Buprenorphine for Analgesia in Older Adults With Acute Fractures in the Emergency Department (NCT07430345) | The Cooper Health System | 2026-05-07 |
| Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection (NCT07555431) | Carlos Brites | 2026-05-07 |
| CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs (NCT07172256) | Yale University | 2026-05-07 |
| Melatonin and Solifenacin for Double-J Ureteral Stent Symptoms (NCT07617922) | Beni-Suef University | 2026-05-07 |
| Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma (NCT06790602) | University of California, San Diego | 2026-05-06 |
| Tamsulosin and Intraureteral Aminophylline for Ureteral Access During RIRS (NCT07623876) | Beni-Suef University | 2026-05-06 |
| Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH) (NCT07318597) | Regeneron Pharmaceuticals | 2026-05-06 |
| Racecadotril for Organ Injury in Sepsis Patients (NCT07454421) | Zhujiang Hospital | 2026-05-06 |
| L-Citrulline Versus Tamsulosin for Medical Expulsive Therapy of Distal Ureteral Stones (NCT07617909) | Beni-Suef University | 2026-05-06 |
| Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Prourokinase (NCT07550296) | General Hospital of Shenyang Military Region | 2026-05-06 |
| Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals (NCT05729503) | University of Calgary | 2026-05-06 |
| A Phase II Study of Sintilimab, Pegaspargase and Selinexor Followed by Radiotherapy in Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma (NCT07574528) | Sun Yat-sen University | 2026-05-06 |
| Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer (NCT07427394) | AstraZeneca | 2026-05-06 |
| Efficacy and Safety of Culmerciclib Plus Aromatase Inhibitors in a Response-Adapted Neoadjuvant Strategy for Highly Proliferative ER-Positive/HER2-Negative Breast Cancer (NCT07616453) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-05-06 |
| A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D) (NCT07545759) | Eli Lilly and Company | 2026-05-06 |
| A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies (NCT07415031) | Mirati Therapeutics Inc. | 2026-05-06 |
| AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL (NCT07594899) | Ruijin Hospital | 2026-05-06 |
| Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma (NCT07567742) | Sun Yat-sen University | 2026-05-06 |
| Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma (NCT07571551) | Jinling Hospital, China | 2026-05-06 |
| Retlirafusp Alfa Combined With Apatinib and Nab-Paclitaxel as Second-line Treatment for Gastric or Gastroesophageal Junction Cancer (NCT07610629) | Henan Cancer Hospital | 2026-05-05 |
| Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC (NCT07452601) | Tang-Du Hospital | 2026-05-05 |
| Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma (NCT07226453) | University of California, San Francisco | 2026-05-05 |
| A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome (NCT07432490) | Oregon Health and Science University | 2026-05-05 |
| Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII (NCT07326566) | Black Diamond Therapeutics, Inc. | 2026-05-05 |
| Postoperative Radiotherapy With Nimotuzumab ± Benmelstobart in Intermediate-Risk Head and Neck Squamous Cell Carcinoma (NCT07535567) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2026-05-05 |
| Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis (NCT06921213) | London School of Hygiene and Tropical Medicine | 2026-05-04 |
| A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors (NCT07488676) | Astellas Pharma Global Development, Inc. | 2026-05-04 |
| Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias (NCT07447817) | John Mascarenhas | 2026-05-04 |
| A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide (NCT06844383) | Prostate Cancer Clinical Trials Consortium | 2026-05-04 |
| Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors (NCT07149207) | Medical University of South Carolina | 2026-05-04 |
| Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD) (NCT07284641) | Paul Szabolcs | 2026-05-04 |
| A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease (NCT07483073) | Eli Lilly and Company | 2026-05-04 |
| Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults (NCT07385287) | Sanaria Inc. | 2026-05-04 |
| A Study to Evaluate BBI-001 in Healthy Volunteers and in Patients With Hereditary Hemochromatosis (NCT07371793) | Bond Biosciences | 2026-05-04 |
| A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease (NCT07483099) | Eli Lilly and Company | 2026-05-04 |
| Disulfiram for Treatment of Retinal Degeneration (NCT05626920) | University of Washington | 2026-05-03 |
| A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008) (NCT07519772) | Merck Sharp & Dohme LLC | 2026-05-03 |
| Boosting Olfactory and Sensory Training Study (BOOST) (NCT07221123) | University of Alabama at Birmingham | 2026-05-02 |
| Methotrexate Treatment in Hand Osteoarthritis Refractory to Usual Treatments (NCT07501507) | Centre Hospitalier Universitaire de Nice | 2026-05-02 |
| The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFLD) (NCT07466485) | Universiti Kebangsaan Malaysia Medical Centre | 2026-05-02 |
| Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases (NCT07343479) | Zhejiang Cancer Hospital | 2026-05-01 |
| External Beam and Radioligand Radiotherapy for mCRPC (NCT07354594) | Centre hospitalier de l'Université de Montréal (CHUM) | 2026-05-01 |
| Neoadjuvant Treatment of Locally Advanced HNSCC With Pertuzumab Combined With Lenvatinib. (NCT07550972) | Zhejiang Provincial People's Hospital | 2026-05-01 |
| Fruquintinib In Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies in South Korea Patients (FIRST-K) (NCT07510932) | Korea University Anam Hospital | 2026-05-01 |
| Study of SA+X in the Treatment of Newly Diagnosed AML (NCT07548710) | Ruijin Hospital | 2026-05-01 |
| A Clinical Study of Iparomlimab and Tuvonralimab Combined With Fruquintinib and Heterogeneous Radiotherapy Versus Fruquintinib as Third-Line and Subsequent-Line Treatment for Metastatic Colorectal Cancer (NCT07502014) | Huazhong University of Science and Technology | 2026-05-01 |
| Lattice-Based Radiotherapy and Chemoimmunotherapy for Oropharyngeal Squamous Cell Carcinoma (NCT07428148) | NYU Langone Health | 2026-05-01 |
| Lesion Sterilization and Tissue Repair Antibiotic Paste Versus Zinc Oxide and Eugenol Pulpectomy for Treatment of Primary Molars With Pulp Necrosis (NCT07475364) | University of Faisalabad | 2026-05-01 |
| Cannabigerol Oil for Adolescents With ADHD (CAN-ADHD) (NCT07592390) | Universidade do Sul de Santa Catarina | 2026-05-01 |
| A Safety and Efficacy Trial of Chidamide Combined With NKG2D CAR-NK Cell Therapy for Reducing the HIV Viral Reservoir (NCT07577986) | First Affiliated Hospital of Zhejiang University | 2026-05-01 |
| Neoadjuvant QL1706 in Patients With Hormone Receptor Positive, HER2-negative Breast Cancer (NCT07396324) | RenJi Hospital | 2026-05-01 |
| Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymarin in Adult Patients With Sepsis (NCT07572552) | Tanta University | 2026-05-01 |
| Study on the Treatment of Double/Triple-hit DLBCL With Chidamide and Lisaftoclax in Combination With Pola-R-CHP (NCT07552324) | Ruijin Hospital | 2026-05-01 |
| Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments (NCT06905834) | Instituto de Investigación Biomédica de Salamanca | 2026-05-01 |
| Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC) (NCT05913674) | Ciusss de L'Est de l'Île de Montréal | 2026-05-01 |
| Phase II Study of Ficerafusp Alfa in Combination With Nivolumab in Patients With Platinum-refractory Head and Neck Squamous Cell Carcinoma (NCT07529873) | Groupe Oncologie Radiotherapie Tete et Cou | 2026-05-01 |
| Using Mirabegron to Control Arrhythmia-1 (NCT07566208) | Cedars-Sinai Medical Center | 2026-05-01 |
| INVESTIGATION OF THE ANTI-NEOPLASTIC EFFECT OF TRISHUL (AYURVEDIC AGENT) ON TUMOUR REGRESSION OF RECTAL CANCER- A PILOT STUDY (NCT07430696) | University of Kelaniya | 2026-05-01 |
| Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDS (NCT05241067) | Pharmazz, Inc. | 2026-05-01 |
| Evaluation of the Efficacy and Safety of Nivolumab Neoadjuvant Treatment of Patients With Locally Advanced Oral Squamous Cell Carcinoma (NCT07514767) | Prof. Lars Olaf Cardell | 2026-05-01 |
| Tiaoshen Anti-cancer Protocol and CBT for Insomnia and Survival in Ovarian Cancer (NCT07550205) | Shanghai Municipal Hospital of Traditional Chinese Medicine | 2026-05-01 |
| Efficacy and Safety of LP-005 Injection in Patients With Moderate-to-Severe Periodontitis (NCT07603713) | Longbio Pharma (Suzhou) Co., Ltd. | 2026-05-01 |
| ADC and SBRT for Recurrent/Metastatic Salivary Gland Carcinoma (NCT07579598) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2026-05-01 |
| Maintenance Zanzalintinib and Durvalumab in Participants With Advanced Hepatocellular Cancer (NCT07226063) | Amit Mahipal | 2026-05-01 |
| Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases (NCT07321847) | Immunophotonics, Inc. | 2026-05-01 |
| Becotatug Vedotin Combined With Pucotenlimab as Neoadjuvant Therapy for Resectable Recurrent Head and Neck Squamous Cell Carcinoma After Progression on Immunotherapy: A Prospective Phase II Study (NCT07589049) | Sun Yat-sen University | 2026-05-01 |
| Mindfulness Engaged Neurostimulation for Depression (MEND II) (NCT07512284) | University of California, San Diego | 2026-05-01 |
| A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma (NCT05874193) | Cristiana Costa Chase, DO | 2026-05-01 |
| Rimegepant Plus Glofitamab and CD19 CAR-T Therapy in R/R LBCL (NCT07613788) | Ruijin Hospital | 2026-05-01 |
| Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD (NCT07610395) | Altesa Biosciences, Inc. | 2026-05-01 |
| Vascular Intervention Strategies Trial for Alzheimer's (NCT07447206) | University of Southern California | 2026-05-01 |
| Intestinal Microbiota Transplantation for Treating Advanced Tumor Cachexia (NCT07533227) | Hua Jiang | 2026-05-01 |
| Short-Course Radiotherapy Followed by Immunotherapy Combined With Chemotherapy for Microsatellite Stable Locally Advanced Rectal Cancer: A Prospective, Randomized, Controlled Phase II Clinical Trial (NCT07594925) | Tianjin Medical University Cancer Institute and Hospital | 2026-05-01 |
| Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma (NCT07505186) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-05-01 |
| PET/MRI in Rectal Cancer (NCT06057831) | AHS Cancer Control Alberta | 2026-05-01 |
| A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer (NCT07543848) | Chongqing University Cancer Hospital | 2026-05-01 |
| A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Cancer (NCT07497919) | Fudan University | 2026-05-01 |
| A Study of BL-M11D1 in Patients With Relapsed/Refractory Myelodysplastic Syndromes (NCT07591168) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-05-01 |
| A Phase II Study of Benmelstobart + Anlotinib + Chemotherapy as First-Line Treatment for LCNEC and EP-NEC (NCT07510594) | Tianjin Medical University Cancer Institute and Hospital | 2026-05-01 |
| To Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease (NCT07422311) | Benuvia Therapeutics Inc. | 2026-05-01 |
| A Study of CSTI-500 in Patients With Prader-Willi Syndrome (NCT07348601) | ConSynance Therapeutics | 2026-05-01 |
| Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS (NCT07579247) | Shanghai Public Health Clinical Center | 2026-05-01 |
| A Multicenter Open-label Phase II Study of Cemiplimab Plus Chemotherapy, Selected on the Basis of Baseline Cytidine Deaminase Activity, in Advanced Squamous Non-small Cell Lung Cancer (NCT07418931) | Gruppo Oncologico Italiano di Ricerca Clinica | 2026-05-01 |
| Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth (NCT06648850) | Applied Biology, Inc. | 2026-05-01 |
| Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer (NCT07490210) | Fudan University | 2026-05-01 |
| Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis (NCT07539779) | Nanfang Hospital, Southern Medical University | 2026-05-01 |
| PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer (NCT07291557) | AHS Cancer Control Alberta | 2026-05-01 |
| Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides (NCT02943642) | Virogen Biotechnology Inc. | 2026-05-01 |
| Inavolisib for PIK3CA Mutated Advanced Endometrial Cancer: MITO END-4 (NCT07522697) | National Cancer Institute, Naples | 2026-05-01 |
| MInimizing Delirium With Nasal Dexmedetomidine-InducEd Sleep (MIDDIES) (NCT07538284) | Sixth Affiliated Hospital, Sun Yat-sen University | 2026-05-01 |
| Long Duration High Frequency Ultrasound for the Treatment of Osteoarthritis (NCT07515872) | ZetrOZ, Inc. | 2026-05-01 |
| A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants (NCT07205796) | Shenzhen Shenxin Biotechnology Co., Ltd | 2026-05-01 |
| Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1 (NCT07598643) | University of Colorado, Denver | 2026-05-01 |
| A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression (NCT07431216) | Starlight Therapeutics Inc. | 2026-05-01 |
| ALTO-207 in Adults With Treatment-resistant Depression (TRD) (NCT07553637) | Alto Neuroscience | 2026-05-01 |
| Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation (NCT07477782) | Assistance Publique - Hôpitaux de Paris | 2026-05-01 |
| A Phase 2 Study of HW091077 in Participants With Refractory Chronic Cough Or Unexplained Chronic Cough (RCC/UCC). (NCT07483489) | Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | 2026-05-01 |
| Denosumab Strategy for Liver Cancer With Bone Metastases (NCT07537972) | Tongji Hospital | 2026-05-01 |
| A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression (NCT07446049) | Convalife (Shanghai) Co., Ltd. | 2026-05-01 |
| Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm Health (NCT07179120) | First Affiliated Hospital of Wenzhou Medical University | 2026-05-01 |